SG11202112880QA - Methods relating to tuberculosis - Google Patents

Methods relating to tuberculosis

Info

Publication number
SG11202112880QA
SG11202112880QA SG11202112880QA SG11202112880QA SG11202112880QA SG 11202112880Q A SG11202112880Q A SG 11202112880QA SG 11202112880Q A SG11202112880Q A SG 11202112880QA SG 11202112880Q A SG11202112880Q A SG 11202112880QA SG 11202112880Q A SG11202112880Q A SG 11202112880QA
Authority
SG
Singapore
Prior art keywords
tuberculosis
methods relating
relating
methods
Prior art date
Application number
SG11202112880QA
Inventor
Benjamin Swift
Catherine Rees
Original Assignee
Pbd Biotech Ltd
Univ Nottingham
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pbd Biotech Ltd, Univ Nottingham filed Critical Pbd Biotech Ltd
Publication of SG11202112880QA publication Critical patent/SG11202112880QA/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/112Disease subtyping, staging or classification

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
SG11202112880QA 2019-05-21 2020-03-05 Methods relating to tuberculosis SG11202112880QA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1907157.0A GB201907157D0 (en) 2019-05-21 2019-05-21 Methods
PCT/GB2020/050524 WO2020234555A1 (en) 2019-05-21 2020-03-05 Methods relating to tuberculosis

Publications (1)

Publication Number Publication Date
SG11202112880QA true SG11202112880QA (en) 2021-12-30

Family

ID=67226285

Family Applications (1)

Application Number Title Priority Date Filing Date
SG11202112880QA SG11202112880QA (en) 2019-05-21 2020-03-05 Methods relating to tuberculosis

Country Status (14)

Country Link
US (1) US20220243258A1 (en)
EP (1) EP3973078B1 (en)
JP (1) JP2022534370A (en)
KR (1) KR20220024127A (en)
CN (1) CN114072524A (en)
AU (1) AU2020277711B2 (en)
BR (1) BR112021023254A2 (en)
CA (1) CA3141503A1 (en)
EA (1) EA202192908A1 (en)
GB (1) GB201907157D0 (en)
MX (1) MX2021014201A (en)
SG (1) SG11202112880QA (en)
WO (1) WO2020234555A1 (en)
ZA (1) ZA202109307B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024092165A1 (en) * 2022-10-26 2024-05-02 The Administrators Of The Tulane Educational Fund Systems and methods for the automated diagnosis of mycobacterial infection

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7776341B2 (en) * 2006-08-10 2010-08-17 Colorado State University Research Foundation Biomarkers of tuberculosis that distinguish disease categories: use as serodiagnostic antigens
CA2758124A1 (en) * 2008-04-19 2009-10-22 New York University Immunodominant mycobacterium tuberculosis peptides from cell wall proteins for early diagnosis and immunization
EP2353008A2 (en) * 2008-09-22 2011-08-10 Oregon Health and Science University Methods for detecting a mycobacterium tuberculosis infection
US8058022B2 (en) * 2009-07-27 2011-11-15 Indian Institute Of Science Diagnosis and monitoring of mycobacterium tuberculosis infection
GB201213567D0 (en) * 2012-07-31 2012-09-12 Proteinlogic Ltd Biomarkers
PL3052650T3 (en) 2013-10-01 2019-09-30 The University Of Nottingham Mycobacteria detection using bacteriophages
GB201401603D0 (en) * 2014-01-30 2014-03-19 Proteinlogic Ltd Biomarkers

Also Published As

Publication number Publication date
MX2021014201A (en) 2022-02-21
EP3973078A1 (en) 2022-03-30
ZA202109307B (en) 2023-04-26
US20220243258A1 (en) 2022-08-04
CN114072524A (en) 2022-02-18
JP2022534370A (en) 2022-07-29
AU2020277711A1 (en) 2022-01-06
GB201907157D0 (en) 2019-07-03
AU2020277711B2 (en) 2024-06-27
KR20220024127A (en) 2022-03-03
EP3973078B1 (en) 2024-07-10
BR112021023254A2 (en) 2022-02-08
EA202192908A1 (en) 2022-03-23
EP3973078C0 (en) 2024-07-10
CA3141503A1 (en) 2020-11-26
WO2020234555A1 (en) 2020-11-26

Similar Documents

Publication Publication Date Title
EP3362579A4 (en) Methods for diagnosis of tuberculosis
IL280913A (en) Novel methods
IL280912A (en) Novel methods
IL289589A (en) Novel methods
GB201803724D0 (en) Methods
GB201907882D0 (en) Methods
GB201621012D0 (en) Improvements relating to pipelaying
HUP1800047A1 (en) Arramgement to aid referees
GB201802486D0 (en) Methods
ZA202109307B (en) Methods relating to tuberculosis
GB201913716D0 (en) Methods
GB201906705D0 (en) Methods
SG11202007342QA (en) Methods
GB201805466D0 (en) Methods
GB201908348D0 (en) Methods
GB201903909D0 (en) Methods
GB201901817D0 (en) Methods
GB201801275D0 (en) Arrangements relating to cryptocurrency
GB201814451D0 (en) Methods
GB2584544B (en) Improvements to letter-plates
GB201901387D0 (en) Improvements relating to pipeliners
GB201901964D0 (en) Improvements relating to surfaces
GB201911910D0 (en) Methods
CA195219S (en) Overall
GB201913754D0 (en) Improvement relating to devices